These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors. Li YP; Ramirez S; Humes D; Jensen SB; Gottwein JM; Bukh J Gastroenterology; 2014 Mar; 146(3):812-821.e4. PubMed ID: 24262279 [TBL] [Abstract][Full Text] [Related]
4. Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection. Jensen TB; Gottwein JM; Scheel TK; Hoegh AM; Eugen-Olsen J; Bukh J J Infect Dis; 2008 Dec; 198(12):1756-65. PubMed ID: 19032070 [TBL] [Abstract][Full Text] [Related]
5. HCV Genotype 6a Escape From and Resistance to Velpatasvir, Pibrentasvir, and Sofosbuvir in Robust Infectious Cell Culture Models. Pham LV; Ramirez S; Gottwein JM; Fahnøe U; Li YP; Pedersen J; Bukh J Gastroenterology; 2018 Jun; 154(8):2194-2208.e12. PubMed ID: 29454794 [TBL] [Abstract][Full Text] [Related]
6. Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77. Li YP; Ramirez S; Mikkelsen L; Bukh J J Virol; 2015 Jan; 89(1):811-23. PubMed ID: 25355880 [TBL] [Abstract][Full Text] [Related]
7. Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations. Scheel TK; Gottwein JM; Carlsen TH; Li YP; Jensen TB; Spengler U; Weis N; Bukh J J Virol; 2011 Mar; 85(6):2891-906. PubMed ID: 21177811 [TBL] [Abstract][Full Text] [Related]
8. Development of full-length cell-culture infectious clone and subgenomic replicon for a genotype 3a isolate of hepatitis C virus. Chen M; Xu Y; Li N; Yin P; Zhou Q; Feng S; Wu T; Wei L; Wang H; Fu Y; Li YP J Gen Virol; 2021 Dec; 102(12):. PubMed ID: 34949310 [TBL] [Abstract][Full Text] [Related]
9. Robust HCV Genotype 3a Infectious Cell Culture System Permits Identification of Escape Variants With Resistance to Sofosbuvir. Ramirez S; Mikkelsen LS; Gottwein JM; Bukh J Gastroenterology; 2016 Nov; 151(5):973-985.e2. PubMed ID: 27453546 [TBL] [Abstract][Full Text] [Related]
11. Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors. Ramirez S; Li YP; Jensen SB; Pedersen J; Gottwein JM; Bukh J Hepatology; 2014 Feb; 59(2):395-407. PubMed ID: 23913364 [TBL] [Abstract][Full Text] [Related]
12. Adapted J6/JFH1-based Hepatitis C virus recombinants with genotype-specific NS4A show similar efficacies against lead protease inhibitors, alpha interferon, and a putative NS4A inhibitor. Gottwein JM; Jensen SB; Serre SB; Ghanem L; Scheel TK; Jensen TB; Krarup H; Uzcategui N; Mikkelsen LS; Bukh J Antimicrob Agents Chemother; 2013 Dec; 57(12):6034-49. PubMed ID: 24060868 [TBL] [Abstract][Full Text] [Related]
13. Current status and future development of infectious cell-culture models for the major genotypes of hepatitis C virus: Essential tools in testing of antivirals and emerging vaccine strategies. Ramirez S; Bukh J Antiviral Res; 2018 Oct; 158():264-287. PubMed ID: 30059723 [TBL] [Abstract][Full Text] [Related]
14. Development of an intergenotypic hepatitis C virus (HCV) cell culture method to assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1 to 6. Imhof I; Simmonds P J Virol; 2010 May; 84(9):4597-610. PubMed ID: 20164226 [TBL] [Abstract][Full Text] [Related]
15. Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systems. Scheel TK; Prentoe J; Carlsen TH; Mikkelsen LS; Gottwein JM; Bukh J PLoS Pathog; 2012; 8(5):e1002696. PubMed ID: 22654662 [TBL] [Abstract][Full Text] [Related]